Showing results (61-70 of 232) with videos related to
Sort By:
Pageof 24
Biochemical Pharmacology|August 22, 2007
Selective serotonin reuptake inhibitors--a new modality for the treatment of lymphoma/leukaemia?Christian Schuster, Nora Fernbach, Uwe Rix, et al.Journal of Proteome Research|December 25, 2015
A Surface Biotinylation Strategy for Reproducible Plasma Membrane Protein Purification and Tracking of Genetic and Drug-Induced AlterationsKatrin Hörmann, Alexey Stukalov, André C Müller, et al.Ebiomedicine|December 27, 2024
Ex vivo imaging-based high content phenotyping of patients with rheumatoid arthritisFelix Kartnig, Michael Bonelli, Ulrich Goldmann, et al.Nature Chemical Biology|January 31, 2012
BCR-ABL uncouples canonical JAK2-STAT5 signaling in chronic myeloid leukemiaOliver Hantschel, Wolfgang Warsch, Eva Eckelhart, et al.Molecular Cell|February 28, 2012
Plk1-dependent phosphorylation of optineurin provides a negative feedback mechanism for mitotic progressionDavid Kachaner, Josina Filipe, Emmanuel Laplantine, et al.Nature Protocols|December 15, 2012
A method to resolve the composition of heterogeneous affinity-purified protein complexes assembled around a common protein by chemical cross-linking, gel electrophoresis and mass spectrometryElena L Rudashevskaya, Roberto Sacco, Klaus Kratochwill, et al.Molecular and Cellular Biology|June 8, 2002
c-Src-mediated phosphorylation of hnRNP K drives translational activation of specifically silenced mRNAsAntje Ostareck-Lederer, Dirk H Ostareck, Christophe Cans, et al.Journal of Virology|January 10, 2014
Virulence factor NSs of rift valley fever virus recruits the F-box protein FBXO3 to degrade subunit p62 of general transcription factor TFIIHMarkus Kainulainen, Matthias Habjan, Philipp Hubel, et al.Molecular Systems Biology|May 12, 2025
The genetic interaction map of the human solute carrier superfamilyGernot Wolf, Philipp Leippe, Svenja Onstein, et al.Oncotarget|December 22, 2017
Sustained activation of the AKT/mTOR and MAP kinase pathways mediate resistance to the Src inhibitor, dasatinib, in thyroid cancerKatie M Mishall, Thomas C Beadnell, Brent M Kuenzi, et al.Pageof 24